DOJ

/Tag:DOJ

Client Alert: Former Heritage Pharmaceuticals Execs Admit to Price Fixing

Former Heritage Pharmaceuticals Execs Admit to Price Fixing Government Continues to Focus on Generic Drug Industry Since early December of 2016, we've been tracking federal price fixing charges brought against two ex-pharmaceutical executives – Jeffrey Glazer and Jason Malek – both formerly of Heritage Pharmaceuticals.  On January 9, 2017, the two entered guilty pleas in [...]

Brian Dickerson, FisherBroyles Partner and authority on Pharmacy Law, interviewed in Special Edition Podcast, “Pharmacy Under Investigation”

FisherBroyles Partner and authority on Pharmacy Law, Brian Dickerson, talks about the increasing Federal Government targeting of pharmacy businesses in an interview on the Pharmacy Podcast Show. The FisherBroyles Pharmacy Law team has observed an increase in the Department of Justice and Department of Defense’s coordinated efforts to conduct investigations into alleged violations of the [...]

Brazilian Conglomerate Odebrecht SA Agrees to Record-Setting Settlement in Bribery Case—Firm Set to Pay Up to $4.5 Billion

December 23, 2016 — In a lengthy statement issued by the U.S. Department of Justice (DOJ) on December 21, 2016, it was announced that Brazilian construction-industry giant Odebrecht SA (Odebrecht) has admitted to violating anti-bribery and corruption laws in a number of countries and agreed to pay between $2.6 and $4.5 billion in a deal to [...]

Client Alert – Twenty States File Suit against Generic Drug Makers-Companies Accused of Collusion and Price-Fixing

On December 14, 2016, we shared the news that two former Heritage Pharmaceuticals (Heritage) executives had been charged by the U.S. Department of Justice in a generic drug pricing-fixing scheme—noting that the investigation was ongoing at both the state and federal levels and could touch dozens of other companies. That statement appears to be prescient, [...]

Two Former Pharm Executives Charged in Generic Drug Price-Fixing Scheme

December 14, 2016 — Today the U.S. Department of Justice (DOJ) charged two former Heritage Pharmaceuticals (Heritage) executives in a price-fixing scheme that reaches far into the generic drug market – with dozens of other companies currently under investigation. A statement issued by the DOJ’s Antitrust Division notes that “the charges are the result of an [...]

Client Alert – Former Valeant and Philidor Execs Charged in Fraud and Kickback Scheme

Little more than a year ago, the complex relationship between pharmaceutical giant Valeant and Philidor Rx Services, a Pennsylvania-based mail-order pharmacy, first drew the attention of government investigators and the press.  Now, two former executives—once from each company—have been charged by federal prosecutors with multiple counts of fraud and conspiracy. On November 17, 2016, ex-Valeant [...]

Express Scripts Subpoenaed as the Feds Initiate Investigations into its Relationships with Drug Manufacturers and Others

October 31, 2016 — The U.S. Department of Justice (DOJ) and two U.S. Attorney's offices have officially entered the national discussion on drug pricing and the role of Pharmacy Benefit Managers (PBMs) with the initiation of investigatory proceedings against Express Scripts. In a recent Securities and Exchange Commission filing, Express Scripts disclosed that it has received [...]

Third Circuit Revives 3rd-party False Claims Act qui tam complaint Against Major Pipe Fitting Manufacturer Victaulic Co.

In a ground-breaking decision, the Court of Appeals for the Third Circuit on October 5, 2016 overruled a decision by the District Court for the Eastern District of Pennsylvania dismissing a qui tam reverse false claim suit filed by “knowledgeable insiders” in the pipe fittings industry.  This decision should be closely reviewed by general counsel [...]

Federal Security Increases for Workers’ Compensation Compounded Medication Claims Paid Pursuant to Federal Employees’ Compensation Act Program

This past June, we issued a client alert regarding an uptick in the Department of Justice and Department of Defense’s coordinated efforts to conduct investigations into alleged violations of the False Claims Act (FCA) for claims submitted to TRICARE and further noted that the Department of Labor (DOL) had joined the enforcement actions for what [...]